Group 1 - The market for major asset restructuring in the Sci-Tech Innovation Board is experiencing strong growth, with 105 major restructuring plans disclosed since the implementation of the "Eight Policies" [1] - As of 2025, there have been 44 new major asset restructuring plans, indicating high market participation [1] Group 2 - Several companies on the Sci-Tech Innovation Board are actively pursuing business synergy through major asset restructuring, such as Aopumai's acquisition of 100% equity in Pengli Bio, enhancing their customer resources and product promotion capabilities [3] - Rapid progress is also seen in Jingyuexing's restructuring efforts, with plans to acquire 100% equity in Jiazhi Hong, reflecting a proactive attitude towards external expansion [3] Group 3 - Significant transactions are drawing market attention, such as the planned stock swap merger between Haiguang Information and Zhongke Shuguang, with market capitalizations of approximately 316.4 billion and 90.6 billion respectively [4] - This merger is expected to achieve deep integration of the industrial chain, enhancing overall competitiveness and impacting the information industry landscape [4] - The fast-paced technology updates and intense market competition in emerging sectors like semiconductors and biomedicine are driving companies to utilize mergers and acquisitions for resource integration and competitive advantage [4]

Investment Rating - The investment rating for the company is "Buy" (maintained) [4] Core Views - The company's performance is under short-term pressure, but the consolidation with China Merchants Railway has led to significant revenue growth [4] - In 2024, the company achieved a revenue of approximately 12.71 billion yuan, a year-on-year increase of 30.62%, while the net profit attributable to shareholders was about 5.32 billion yuan, a decrease of 21.35% [6] - The company is focusing on its core business and has successfully completed the transition of the management of the Road King asset package, adding 276 kilometers of operational mileage [6] Financial Summary - Revenue projections for 2023 to 2027 are as follows: 9.73 billion yuan (2023), 12.71 billion yuan (2024), 12.90 billion yuan (2025E), 13.23 billion yuan (2026E), and 13.60 billion yuan (2027E) [5] - The net profit attributable to shareholders is projected to be 6.77 billion yuan (2023), 5.32 billion yuan (2024), 5.74 billion yuan (2025E), 6.19 billion yuan (2026E), and 6.70 billion yuan (2027E) [5] - The company’s return on equity (ROE) is expected to be 10.40% (2023), 7.47% (2024), 7.65% (2025E), 7.84% (2026E), and 8.05% (2027E) [5] Market Performance - The company reported a gross margin of 34.09% in 2024, a decrease of 2.87 percentage points year-on-year, primarily due to asset optimization and adverse weather conditions [6] - The company’s operating expenses increased due to the consolidation with China Merchants Railway, with a total expense ratio of 20.92% in 2024, up by 1.34 percentage points year-on-year [6] Strategic Initiatives - The company is actively pursuing expansion strategies and has made progress on various upgrade and expansion projects, including the completion of internal project approvals for the Ningbo-Taizhou-Wenzhou Expressway southern section [6] - The company has also completed the acquisition of the remaining 40% equity in Hunan Yonglan Expressway and is advancing the preliminary engineering for several other projects [6]